During the past years, there has been increasing demand for fast dissolving disintegrating tablets (FDDTs), such as orally disintegrating tablets (ODTs) and sublinguals. During the past years, there ...
NEW HAVEN, Conn., Jan. 9, 2018 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven" or the "Company") announced positive results today from its bioequivalence study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback